Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis enabler. These devices have large commercial potential


TSX:EDT - Post by User

Comment by GoldMemberTon Nov 02, 2021 11:34pm
92 Views
Post# 34080547

RE:27 cents. You don’t need to be an expert stockhouse troll

RE:27 cents. You don’t need to be an expert stockhouse troll

The sad truth is that the company is to blame for the share price not any magic entity 

GoldMemberT wrote:

to see that 

they pulled a fast one for a financing and haven't had a significant non fluff piece of news since. That in and of itself is just akin spitting in investors faces.

they haven't spun out dialco as promised

they don't have a partner that they claimed they would have for Dialco.

no news on continued "heightened enrolment"

no start of dimi trial

The company did not live up to the promise of 15 hospitals recruiting by the end of Q3

investor presentation says 60% enrolment for PMX by DECEMBER but on clinicaltrials.gov it's slated for March (I bet that will get moved too). 

literally can not get the company to pick up their phone which actually aside from here does not exist anywhere else. Even the worst of companies have someone for investors to talk to. Most of the time the CEO does it to save on cost but in this case they can't even spend 50k on a recent grad. 



<< Previous
Bullboard Posts
Next >>